Globus Medical Company Profile (NYSE:GMED)

About Globus Medical

Globus Medical logoGlobus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: GMED
  • CUSIP: 37957720
Key Metrics:
  • Previous Close: $27.62
  • 50 Day Moving Average: $25.88
  • 200 Day Moving Average: $23.50
  • 52-Week Range: $19.25 - $28.17
  • Trailing P/E Ratio: 22.64
  • Foreward P/E Ratio: 22.08
  • P/E Growth: 2.00
  • Market Cap: $2.65B
  • Outstanding Shares: 95,825,000
  • Beta: 0.63
Profitability:
  • Net Margins: 21.20%
  • Return on Equity: 14.92%
  • Return on Assets: 13.23%
Debt:
  • Current Ratio: 7.27%
  • Quick Ratio: 5.51%
Additional Links:
Companies Related to Globus Medical:

Analyst Ratings

Consensus Ratings for Globus Medical (NYSE:GMED) (?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.15)
Consensus Price Target: $25.00 (10.84% downside)

Analysts' Ratings History for Globus Medical (NYSE:GMED)
Show:
DateFirmActionRatingPrice TargetDetails
1/23/2017Canaccord GenuityReiterated RatingHold$27.00View Rating Details
11/30/2016AegisInitiated CoverageBuy$31.00View Rating Details
11/9/2016Leerink SwannReiterated RatingHold$23.00View Rating Details
11/9/2016Oppenheimer Holdings, Inc.DowngradeOutperform -> Market Perform$29.00 -> $23.00View Rating Details
11/9/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
11/9/2016Citigroup Inc.DowngradeMarket Perform$29.00 -> $23.00View Rating Details
11/9/2016JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
7/28/2016Morgan StanleyLower Price TargetEqual Weight$28.00 -> $25.00View Rating Details
7/27/2016Barclays PLCLower Price TargetEqual Weight$26.00 -> $25.00View Rating Details
7/27/2016Wells Fargo & CompanyDowngradeOutperform -> Market Perform$23.00View Rating Details
6/25/2016Piper Jaffray CompaniesReiterated RatingOverweight$29.00View Rating Details
5/26/2016Goldman Sachs Group, Inc. (The)DowngradeNeutral -> Sell$21.00View Rating Details
5/4/2016Brean CapitalReiterated RatingBuyView Rating Details
1/8/2016Bank of America CorpDowngradeBuy -> Underperform$28.00View Rating Details
3/2/2015WallachBeth CapitalBoost Price TargetBuy$26.00 -> $30.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Globus Medical (NYSE:GMED)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2017Q416$0.33$149.30 millionListenView Earnings Details
11/8/2016Q3$0.28$0.29$139.25 million$135.70 millionViewListenView Earnings Details
7/26/2016Q2$0.29$0.29$141.78 million$137.49 millionViewListenView Earnings Details
5/3/2016Q1$0.28$0.29$140.30 million$139.30 millionViewListenView Earnings Details
2/24/2016Q4$0.30$0.32$141.20 million$142.60 millionViewListenView Earnings Details
11/3/2015Q3$0.25$0.28$127.46 million$137.00 millionViewListenView Earnings Details
7/30/2015Q215$0.25$0.25$126.89 million$133.60 millionViewListenView Earnings Details
5/5/2015Q115$0.24$0.26$122.30 million$131.60 millionViewListenView Earnings Details
2/25/2015Q414$0.25$0.30$127.77 million$128.80 millionViewListenView Earnings Details
10/30/2014Q314$0.21$0.24$113.10 million$117.80 millionViewListenView Earnings Details
8/5/2014Q214$0.23$0.23$119.83 million$113.60 millionViewListenView Earnings Details
4/29/2014Q114$0.22$0.24$113.59 million$114.20 millionViewListenView Earnings Details
2/26/2014Q413$0.22$0.25$114.96 million$115.20 millionViewListenView Earnings Details
10/30/2013Q313$0.19$0.22$106.00 million$107.19 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.20$0.21$107.46 million$107.00 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.20$0.21$103.14 million$105.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.19$0.22$99.13 million$100.50 millionViewListenView Earnings Details
11/1/2012Q312$0.19$0.18$95.32 million$94.76 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Globus Medical (NYSE:GMED)
Current Year EPS Consensus Estimate: $1.20 EPS
Next Year EPS Consensus Estimate: $1.27 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.27$0.28$0.28
Q2 20162$0.27$0.28$0.28
Q3 20162$0.30$0.31$0.31
Q4 20161$0.32$0.32$0.32
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Globus Medical (NYSE:GMED)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Globus Medical (NYSE:GMED)
Insider Ownership Percentage: 27.93%
Institutional Ownership Percentage: 88.55%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/5/2016A Brett MurphyInsiderSell107,692$23.37$2,516,762.04View SEC Filing  
1/6/2016Robert LiptakDirectorSell15,300$27.50$420,750.00View SEC Filing  
1/4/2016Kurt WheelerDirectorSell255$27.50$7,012.50View SEC Filing  
5/28/2015Steven PayneCAOSell3,076$25.92$79,729.92View SEC Filing  
3/19/2015David C PaulCEOSell1,922,000$25.00$48,050,000.00View SEC Filing  
1/15/2014David DemskiCOOSell96,813$20.51$1,985,634.63View SEC Filing  
12/31/2013David DemskiCOOSell3,187$20.25$64,536.75View SEC Filing  
12/20/2013David DemskiCOOSell50,000$19.75$987,500.00View SEC Filing  
12/6/2013Robert LiptakDirectorSell25,000$19.36$484,000.00View SEC Filing  
12/3/2013David DavidarVPSell75,000$19.25$1,443,750.00View SEC Filing  
11/27/2013David DemskiCOOSell37,323$19.25$718,467.75View SEC Filing  
11/1/2013David M DemskiCOOSell112,677$18.59$2,094,665.43View SEC Filing  
8/23/2013David DavidarVPSell7,278$18.20$132,459.60View SEC Filing  
8/22/2013David DemskiCOOSell44,154$17.95$792,564.30View SEC Filing  
7/5/2013David D DavidarVPSell10,000$17.15$171,500.00View SEC Filing  
7/1/2013David D DavidarVPSell20,000$16.56$331,200.00View SEC Filing  
6/26/2013David D DavidarVPSell150,000$16.71$2,506,500.00View SEC Filing  
8/8/2012David C PaulCEOSell3,039,385$11.16$33,919,536.60View SEC Filing  
8/8/2012David D DavidarVPSell166,885$11.16$1,862,436.60View SEC Filing  
8/8/2012David M DemskiCOOSell98,957$11.16$1,104,360.12View SEC Filing  
8/8/2012Kurt WheelerDirectorSell804,232$11.16$8,975,229.12View SEC Filing  
8/8/2012Steven PayneCAOSell2,305$11.16$25,723.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Globus Medical (NYSE:GMED)
DateHeadline
realistinvestor.com logoDeferred Tax Assets Of Globus Medical, Inc. (NYSE:GMED) At $38.687 Millions - RealistInvestor.com (NYSE:GMED)
www.realistinvestor.com - February 17 at 8:48 AM
News IconTarget Price Review & Stock Update on Globus Medical, Inc. (NYSE:GMED) - Rockville Register (NYSE:GMED)
rockvilleregister.com - February 17 at 8:48 AM
News IconAre Analysts Optimistic About Where Globus Medical, Inc. (NYSE:GMED) is Heading? - Winfield Review (NYSE:GMED)
winfieldreview.com - February 17 at 8:48 AM
News IconTracking the Numbers for Globus Medical, Inc. (NYSE:GMED) - Davidson Register (NYSE:GMED)
davidsonregister.com - February 13 at 11:24 PM
realistinvestor.com logoThe Growth Forecast For Globus Medical, Inc. (NYSE:GMED) - RealistInvestor.com (NYSE:GMED)
www.realistinvestor.com - February 11 at 5:33 PM
finance.yahoo.com logoGlobus Medical to Present at Leerink Partners 6th Annual Global Healthcare Conference 2017 (NYSE:GMED)
finance.yahoo.com - February 9 at 6:17 PM
finance.yahoo.com logoGlobus Medical Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call (NYSE:GMED)
finance.yahoo.com - February 7 at 6:45 PM
realistinvestor.com logoGlobus Medical, Inc. (NYSE:GMED) Analysts Rating At 2.58 - RealistInvestor.com (NYSE:GMED)
www.realistinvestor.com - February 2 at 11:02 PM
News IconF-Score Review on Shares of Globus Medical, Inc. (NYSE:GMED) - The Tribune (NYSE:GMED)
lakecitytribune.com - January 29 at 5:30 PM
bizjournals.com logoTechnical Reports on Medical Equipment Stocks -- Sunshine Heart, Globus Medical, Align Technology, and ZELTIQ Aesthetics (NYSE:GMED)
www.bizjournals.com - January 28 at 12:23 AM
News IconInvestor Watch: Checking in on Shares of Globus Medical, Inc. (NYSE:GMED) - The Tribune (NYSE:GMED)
lakecitytribune.com - January 27 at 7:22 PM
4-traders.com logoGlobus Medical : Patent Issued for Standalone Interbody Implants (USPTO 9545320) (NYSE:GMED)
www.4-traders.com - January 26 at 11:57 PM
News IconFirst Week of September 15th Options Trading For Globus Medical (GMED) (NYSE:GMED)
www.stockoptionschannel.com - January 24 at 11:15 PM
News IconEarnings in Full Force, Analysts Take Aim at Globus Medical, Inc. (NYSE:GMED) - Wall Street Beacon (NYSE:GMED)
wsbeacon.com - January 24 at 6:11 PM
News IconGlobus Medical Inc. (GMED) stock falls, "Hold" rating reiterated by Canaccord Genuity Analysts - BNB Daily (blog) (NYSE:GMED)
www.baseball-news-blog.com - January 24 at 6:11 PM
News IconTechnical Review on Shares of Globus Medical Inc. (GMED) - Springdale Times (NYSE:GMED)
springdaletimes.com - January 22 at 5:22 PM
realistinvestor.com logoGlobus Medical, Inc. (NYSE:GMED) Mean Rating At $2.58 - RealistInvestor.com (NYSE:GMED)
www.realistinvestor.com - January 22 at 5:22 PM
News IconWill The Needle Move For Globus Medical, Inc. (NYSE:GMED) Shares This Earnings Season? - Wall Street Beacon (NYSE:GMED)
wsbeacon.com - January 17 at 9:19 AM
News IconMarkets End Mostly Higher, How Did This Stock Fare: Globus ... - Wall Street Beacon (NYSE:GMED)
wsbeacon.com - January 15 at 5:10 PM
News IconStock Vaulting to Uncharted Territory: Globus Medical, Inc. (NYSE:GMED) - Wall Street Beacon (NYSE:GMED)
wsbeacon.com - January 13 at 8:22 AM
News IconGlobus Medical, Inc. GMED Medical Equipment Deals and Alliances Profile Prices from USD $250 (NYSE:GMED)
www.bioportfolio.com - January 10 at 11:25 PM
us.rd.yahoo.com logoGlobus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results (NYSE:GMED)
us.rd.yahoo.com - January 10 at 11:25 PM
us.rd.yahoo.com logo5:10 pm Globus Medical reports prelim Q4 sales above consensus and issues FY17 guidance in-line (NYSE:GMED)
us.rd.yahoo.com - January 10 at 11:25 PM
News IconLarge Outflow of Money Witnessed in Globus Medical, Inc. - Highland Mirror (NYSE:GMED)
www.highlandmirror.com - January 10 at 6:25 PM
streetinsider.com logoGlobus Medical (GMED) Q4 Prelim. Revenue Tops Views - StreetInsider.com (NYSE:GMED)
www.streetinsider.com - January 10 at 6:25 PM
biz.yahoo.com logoGLOBUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition (NYSE:GMED)
biz.yahoo.com - January 10 at 6:25 PM
feeds.reuters.com logoBRIEF-Globus medical sees FY 2016 sales up 3.5 pct to $625 mln (NYSE:GMED)
feeds.reuters.com - January 10 at 6:18 PM
realistinvestor.com logoResearch Analysts Set Globus Medical, Inc. (NYSE:GMED) Price Target at $24.75 - RealistInvestor.com (NYSE:GMED)
www.realistinvestor.com - January 9 at 3:17 AM
globenewswire.com logoGlobus Medical Announces CE Mark for Excelsius GPS™ - GlobeNewswire (press release) (NYSE:GMED)
globenewswire.com - January 6 at 11:05 PM
kcregister.com logoGlobus Medical, Inc. (NYSE:GMED) announces that Excelsius GPS is now CE marked (NYSE:GMED)
www.kcregister.com - January 6 at 6:00 PM
streetinsider.com logoGlobus Medical (GMED) Reports CE Mark for Excelsius GPS (NYSE:GMED)
www.streetinsider.com - January 5 at 11:26 PM
finance.yahoo.com logo4:17 pm Globus Medical announces that the Excelsius GPS is now CE marked (NYSE:GMED)
finance.yahoo.com - January 5 at 6:25 PM
publicnow.com logoGlobus Medical Announces CE Mark for Excelsius GPS™ (NYSE:GMED)
www.publicnow.com - January 5 at 6:25 PM
realistinvestor.com logoGlobus Medical, Inc. (NYSE:GMED) Accounts Payable Is $13.936 For The Quarter ... (NYSE:GMED)
www.realistinvestor.com - January 4 at 11:32 PM
capitalcube.com logoETFs with exposure to Globus Medical, Inc. : January 3, 2017 (NYSE:GMED)
www.capitalcube.com - January 3 at 7:53 PM
News IconChecking the Levels on Shares of Globus Medical, Inc. (NYSE:GMED) - The Business Journal (NYSE:GMED)
belmontbusinessjournal.com - December 21 at 3:28 AM
News IconChart Trading: Viewing CCI and ADX Levels for Globus Medical Inc. (GMED) - StockTalk Daily (NYSE:GMED)
stocktalkdaily.com - December 21 at 3:28 AM
capitalcube.com logoETFs with exposure to Globus Medical, Inc. : December 19, 2016 (NYSE:GMED)
www.capitalcube.com - December 20 at 10:38 AM
News IconEquity Rundown: RSI and CCI Check on Globus Medical Inc. (GMED) - StockTalk Daily (NYSE:GMED)
stocktalkdaily.com - December 17 at 10:44 PM
News IconF-Score Review on Shares of Globus Medical, Inc. (NYSE:GMED) - The Business Journal (NYSE:GMED)
belmontbusinessjournal.com - December 15 at 11:05 PM
News IconInvestor Guide: Check on Technical Levels for Globus Medical Inc. (GMED) - StockTalk Daily (NYSE:GMED)
stocktalkdaily.com - December 14 at 11:07 PM
investornewswire.com logoStrong Sell Recommendations Of Globus Medical, Inc. (NYSE:GMED) At 0 - Investor Newswire (NYSE:GMED)
www.investornewswire.com - December 12 at 5:36 PM
News IconGlobus Medical, Inc. (GMED) Class A Stock Sees Significant Volume Spike Moving Into 2017 (NYSE:GMED)
blog.qualitystocks.net - December 9 at 10:20 AM
capitalcube.com logoETFs with exposure to Globus Medical, Inc. : December 6, 2016 (NYSE:GMED)
www.capitalcube.com - December 6 at 5:37 PM
capitalcube.com logoGlobus Medical, Inc. breached its 50 day moving average in a Bullish Manner : GMED-US : December 6, 2016 (NYSE:GMED)
www.capitalcube.com - December 6 at 10:47 AM
News IconTrading Ledger: Keeping an Eye on Globus Medical, Inc. (NYSE:GMED) - The Business Journal (NYSE:GMED)
belmontbusinessjournal.com - December 5 at 11:22 AM
streetinsider.com logoGlobus Medical (GMED), UMB Financial (UMBF) to UMB Financial; HomeStreet (HMST) to S&P SmallCap 600 - StreetInsider.com (NYSE:GMED)
www.streetinsider.com - December 5 at 11:22 AM
realistinvestor.com logoMean Rating Of Globus Medical, Inc. (NYSE:GMED) At $2.58 - RealistInvestor.com (NYSE:GMED)
www.realistinvestor.com - December 4 at 10:39 AM
News IconGlobus Medical and UMB Financial Set to Join S&P MidCap 400 HomeStreet to Join S&P SmallCap 600 (NYSE:GMED)
menafn.com - December 3 at 10:32 AM
realistinvestor.com logoAnalysts Rating Of Globus Medical, Inc. (NYSE:GMED) At 2.73 - RealistInvestor.com (NYSE:GMED)
www.realistinvestor.com - December 1 at 10:39 PM

Social

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

Where is Globus Medical's stock going? Where will Globus Medical's stock price be in 2017?

13 brokers have issued 1 year target prices for Globus Medical's stock. Their predictions range from $21.00 to $31.00. On average, they anticipate Globus Medical's share price to reach $25.00 in the next year.

When will Globus Medical announce their earnings?

Globus Medical is scheduled to release their next quarterly earnings announcement on Wednesday, February, 22nd 2017.

Who owns Globus Medical stock?

Globus Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Janus Capital Management LLC (3.41%), Aberdeen Asset Management PLC UK (2.52%), State Street Corp (2.26%), Dimensional Fund Advisors LP (1.86%), Deerfield Management Co. (1.08%) and Marshall Wace LLP (0.57%). Company insiders that own Globus Medical stock include A Brett Murphy, David C Paul, Kurt Wheeler, Robert Liptak and Steven Payne.

Who sold Globus Medical stock? Who is selling Globus Medical stock?

Globus Medical's stock was sold by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Tudor Investment Corp Et Al, Two Sigma Investments LP, Fiera Capital Corp, Guggenheim Capital LLC, AQR Capital Management LLC, Thrivent Financial for Lutherans and Paradigm Asset Management Co. LLC.

Who bought Globus Medical stock? Who is buying Globus Medical stock?

Globus Medical's stock was bought by a variety of institutional investors in the last quarter, including Deerfield Management Co., State Street Corp, Marshall Wace LLP, FMR LLC, Aberdeen Asset Management PLC UK, Dimensional Fund Advisors LP, Russell Investments Group Ltd. and Menta Capital LLC.

How do I buy Globus Medical stock?

Shares of Globus Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Globus Medical stock cost?

One share of Globus Medical stock can currently be purchased for approximately $28.04.

Globus Medical (NYSE:GMED) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Globus Medical (NYSE:GMED)

Earnings History Chart

Earnings by Quarter for Globus Medical (NYSE:GMED)

Dividend History Chart

Dividend Payments by Quarter for Globus Medical (NYSE:GMED)

Last Updated on 2/22/2017 by MarketBeat.com Staff